- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Nectar Lifesciences has submitted a revised, legible newspaper copy of its financial results for the quarter ended June 30, 2025. This update ensures that all stakeholders, particularly retail investors, have clear and accurate access to the company's latest financial performance data. Providing legible documents is vital for transparency and helps investors properly assess the company's recent business operations and financial health.